omniture

匯邦集團(tuán)控股有限公司(納斯達(dá)克:AGBA)宣布2023年第一季度業(yè)績(jī) 中國(guó)內(nèi)地及香港經(jīng)濟(jì)反彈提供巨大增長(zhǎng)機(jī)會(huì)

2023年第一季度收入為1,110萬(wàn)美元,較2022年同期大幅增長(zhǎng)533%

香港2023年5月15日 /美通社/ -- 納斯達(dá)克上市、香港領(lǐng)先的一站式金融超市匯邦集團(tuán)控股有限公司(AGBA),欣然宣布2023年第一季度的財(cái)務(wù)業(yè)績(jī),期內(nèi)收入為1,110萬(wàn)美元,較2022年同比大幅增長(zhǎng)逾5倍。 

2023年3月期間,AGBA集團(tuán)錄得過(guò)去三年內(nèi)最多的新業(yè)務(wù)申請(qǐng)。 AGBA預(yù)期今年剩余季度集團(tuán)將繼續(xù)保持強(qiáng)勁增長(zhǎng)。 AGBA集團(tuán)對(duì)香港的經(jīng)濟(jì)反彈感到樂(lè)觀,認(rèn)為反彈有賴邊境重新開(kāi)放、內(nèi)地游客的回歸以及疫情后強(qiáng)勁的國(guó)內(nèi)需求。

2023年第一季度, AGBA 集團(tuán)繼續(xù)進(jìn)行科技部署,在客戶平臺(tái)(client portal)和顧問(wèn)工具方面持續(xù)提升客戶體驗(yàn)。 在平臺(tái)業(yè)務(wù)方面,AGBA集團(tuán)引入10個(gè)新保險(xiǎn)合作伙伴,新增170種以上新保險(xiǎn)和投資產(chǎn)品至現(xiàn)時(shí)總共超過(guò)2千款金融產(chǎn)品;在分銷業(yè)務(wù)方面,AGBA集團(tuán)與三個(gè)新分銷合作伙伴,以及一家大型本地銀行簽訂合作協(xié)議使用One Platform環(huán)一平臺(tái)服務(wù)。 同時(shí),集團(tuán)還啟動(dòng)了一個(gè)新的孵化分銷渠道,與較小型的顧問(wèn)團(tuán)隊(duì)合作。 

2023年4月,AGBA集團(tuán)與新加坡的Sony Life Financial Advisors達(dá)成收購(gòu)協(xié)議,繼續(xù)推動(dòng)AGBA集團(tuán)的環(huán)球擴(kuò)張計(jì)劃,該公司為新加坡一家持牌金融顧問(wèn)和保險(xiǎn)經(jīng)紀(jì)公司。 這一收購(gòu)為AGBA集團(tuán)在大灣區(qū)以外,擴(kuò)展至東南亞的重要里程碑。

同樣在2023年4月,AGBA集團(tuán)宣布了一項(xiàng)回購(gòu)計(jì)劃,最多回購(gòu)100萬(wàn)股(最高價(jià)值1,000萬(wàn)美元)。 回購(gòu)反映AGBA集團(tuán)致力回饋股東,為股東帶來(lái)價(jià)值,同時(shí)保持財(cái)務(wù)靈活性,以投資高增長(zhǎng)機(jī)會(huì)。

匯邦集團(tuán)控股有限公司集團(tuán)總裁吳榮輝表示香港經(jīng)濟(jì)反彈和內(nèi)地游客的回歸,加上我們持續(xù)對(duì)創(chuàng)新和擴(kuò)張的承諾,為AGBA集團(tuán)帶來(lái)一個(gè)充滿成長(zhǎng)和繁榮的精彩季度。 我們將繼續(xù)致力于投資我們的業(yè)務(wù),創(chuàng)造創(chuàng)新的技術(shù)并擴(kuò)大我們的產(chǎn)品范圍,以保持領(lǐng)先地位并把握香港獨(dú)特的機(jī)遇。 2023 年對(duì)AGBA 的所有人來(lái)說(shuō)將是令人興奮無(wú)比的一年。 

有關(guān)AGBA集團(tuán) 2023 年第一季度財(cái)務(wù)業(yè)績(jī)和未來(lái)展望的詳細(xì)分析,請(qǐng)參閱集團(tuán)網(wǎng)站 www.agba.com/ir。 

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the outcome of any legal proceedings that may be instituted against us following the consummation of the business combination; expectations regarding our strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and our ability to invest in growth initiatives and pursue acquisition opportunities; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Hong Kong and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including its impacts across our business and operations. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

關(guān)于AGBA集團(tuán)

AGBA集團(tuán)(納斯達(dá)克:"AGBA")成立于1993年,是一家以香港為基地的領(lǐng)先一站式金融超市,在粵港澳大灣區(qū)提供最廣泛的金融和醫(yī)療保健服務(wù),通過(guò)以技術(shù)為主導(dǎo)的生態(tài)系統(tǒng),讓客戶能夠選擇最適合他們需求的方案。AGBA擁有四大業(yè)務(wù):平臺(tái)業(yè)務(wù)、分銷業(yè)務(wù)、醫(yī)療保健業(yè)務(wù)和金融科技業(yè)務(wù),均領(lǐng)先市場(chǎng),深受超過(guò)400,000名個(gè)人和企業(yè)客戶的信賴。

如欲了解AGBA更多資料,請(qǐng)瀏覽AGBA網(wǎng)站: http://www.agba.com 

社交媒體:
agbagroup
LinkedIn | Twitter | Instagram | Facebook | YouTube

消息來(lái)源:AGBA Group Holding Limited
相關(guān)股票:
NASDAQ:AGBA
China-PRNewsire-300-300.png
醫(yī)藥健聞
微信公眾號(hào)“醫(yī)藥健聞”發(fā)布全球制藥、醫(yī)療、大健康企業(yè)最新的經(jīng)營(yíng)動(dòng)態(tài)。掃描二維碼,立即訂閱!
collection